ISDS Case Map
health
Previous negotiations have stalled because of red lines on the NHS and food standards - so what sort of deal could Labour achieve after the Starmer charmer offensive?
Civil society and non-government organizations in Thailand oppose the provisions proposed by the EU that will have a vast and adverse impact on access to medicines, universal health coverage scheme, agriculture, food sovereignty, consumer protection, and livelihoods of Thai people.
Thai civil society groups, including FTA Watch and the Thai Network of People Living with HIV/AIDS, have expressed serious concerns over the ongoing Thailand-EU Free Trade Agreement negotiations. Key issues include stricter intellectual property rights, which could impact access to affordable medicines, and potential threats to food security and public health. The groups are urging the Thai government to prioritize public health and environmental concerns over corporate interests.
Civil society groups in Thailand and Switzerland are urging the Thai government to maintain its stance against TRIPS+ provisions, which exceed the requirements of the World Trade Organization's TRIPS Agreement. These groups argue that such provisions could significantly increase the cost of medicines and limit access for the Thai population.
Republicans' Project 2025 manifesto suggests opening up NHS to 'foreign competition'.
India and South East Asian nation Cambodia deliberated upon diversification of the trade basket by identifying new products, bilateral investment treaty, recognition of Indian pharmacopoeia and collaboration in the pharma sector.
It is no coincidence that just five days before the amendments were announced, India signed a Free Trade Agreement with the European Free Trade Association.
MSF is concerned that certain clauses related to intellectual property in this trade deal could significantly undermine the use of existing public health measures enshrined in Indian patent law.
Thirty years after NAFTA came into effect in 1994, the economic data suggests a somber conclusion: The three countries’ working classes are worse off today than they were before
Intellectual property protection for the Swiss pharmaceutical industry has been a key sticking point in negotiations on a free trade agreement with India. Now there seems to be a breakthrough in talks after 16 years. What’s changed?
